ARTICLE | Clinical News
Carbaglu regulatory update
November 23, 2009 8:00 AM UTC
FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Jan. 13 to discuss an NDA from Recordati for Carbaglu carglumic acid to treat hyperammonemia in patients with N-acetylglutamate...